Crinetics Pharmaceuticals (CRNX) Change in Acquisitions & Divestments (2019 - 2026)

Crinetics Pharmaceuticals' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $302.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 1.17% year-over-year to $302.9 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 51.17% YoY), while the FY2025 annual figure was $1.2 billion, up 105.64% from the prior year.
• Change in Acquisitions & Divestments was $302.9 million for Q1 2026 at Crinetics Pharmaceuticals, up from $271.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $382.4 million in Q3 2025 to a low of $11.7 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $150.4 million across 5 years, with a median of $101.4 million in 2024.
• Biggest YoY gain for Change in Acquisitions & Divestments was 28870.49% in 2022; the steepest drop was 66.66% in 2022.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $70.7 million in 2022, then advanced by 22.62% to $86.7 million in 2023, then soared by 112.24% to $184.0 million in 2024, then soared by 47.42% to $271.2 million in 2025, then advanced by 11.68% to $302.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $302.9 million (Q1 2026), $271.2 million (Q4 2025), and $382.4 million (Q3 2025), per Business Quant data.